Literature DB >> 22004222

High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy.

Takashi Kawahara1, Hisashi Oshiro, Zenkichi Sekiguchi, Hiroki Ito, Kazuhide Makiyama, Hiroji Uemura, Yoshinobu Kubota.   

Abstract

We report a case of high-grade invasive urothelial carcinoma with plasmacytoid differentiation of the urinary bladder. A 75-year-old woman was referred to our hospital because of macroscopic hematuria. Cystoscopy detected a solid pedunculated bladder tumor, and a transurethral resection of the bladder tumor (TUR-Bt) and the image findings showed pT1N0M0 bladder cancer. The histopathological examination revealed the coexistence of a large component of high-grade invasive urothelial carcinoma and a small component of plasmacytoid carcinoma. Following the TUR-Bt, external beam radiotherapy and chemotherapy with gemcitabine and nedaplatin were carried out. The bladder tumor has not recurred for 2 years after the TUR-Bt.
© 2011 The Japanese Urological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22004222     DOI: 10.1111/j.1442-2042.2011.02880.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  5 in total

1.  Organ-confined plasmacytoid urothelial carcinoma: implication of the lack of expression of the receptor tyrosine kinase MET.

Authors:  Chiemi Saigo; Koji Iinuma; Koji Kameyama; Kosuke Mizutani; Masahiro Nakano; Yusuke Kito; Tamotsu Takeuchi
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.

Authors:  Shinji Ohtake; Takashi Kawahara; Ryo Kasahara; Hiroki Ito; Kimito Osaka; Yusuke Hattori; Jun-Ichi Teranishi; Kazuhide Makiyama; Nobuhiko Mizuno; Susumu Umemoto; Yasuhide Miyoshi; Noboru Nakaigawa; Hiroshi Miyamoto; Masahiro Yao; Hiroji Uemura
Journal:  Biomed Res Int       Date:  2016-09-08       Impact factor: 3.411

3.  A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.

Authors:  Ryo Kasahara; Takashi Kawahara; Shinji Ohtake; Yoko Saitoh; Sohgo Tsutsumi; Jun-Ichi Teranishi; Yasuhide Miyoshi; Noboru Nakaigawa; Masahiro Yao; Kazuki Kobayashi; Hiroji Uemura
Journal:  Biomed Res Int       Date:  2017-04-13       Impact factor: 3.411

Review 4.  Metastatic Plasmacytoid Bladder Cancer Harboring a CDH-1 Mutation and Producing High Levels of CA 19-9. A Case Report and Literature Review.

Authors:  Mohammad Telfah; Rahul A Parikh; Da Zhang; Anup Kasi
Journal:  Am J Case Rep       Date:  2020-07-09

5.  Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report.

Authors:  Mari Ohtaka; Takashi Kawahara; Yohei Kumano; Yoko Maeda; Takuya Kondo; Taku Mochizuki; Hiroaki Ishida; Yusuke Hattori; Jun-ichi Teranishi; Yasuhide Miyoshi; Yasushi Yumura; Masahiro Yao; Yoshiaki Inayama; Hiroji Uemura
Journal:  J Med Case Rep       Date:  2016-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.